glp-1 telehealth crackdown news today Last month, the FDA issued 25 warning letters to companies over what it called false or misleading claims about compounded medications. Read more at the link in the comments below FDA GLP-1 Compounding Crackdown

Can I Use This Peptide If I Have Skin Cancer or Undergoing Treatment

Sometimes you may feel the pain from your abdomen to your back

Matching Medications to Individual Needs Not every medication fits every patient, and the program is designed with this in mind

Taken together, the figure highlights a key mechanistic principle underlying the therapeutic rationale for multi-agonist strategies: while GLP-1R monotherapy achieves meaningful metabolic and hepatic benefits exclusively through indirect, systemic pathways, the addition of GIPR and - most importantly - GCGR co-agonism introduces complementary and increasingly direct hepatic mechanisms, providing the pharmacological basis for the superior efficacy observed with dual and triple agonists in MASLD/MASH